| Dr William M Beary, MD | |
|
6420 Prospect Ave Ste T303, Kansas City, MO 64132-4146 | |
| (816) 333-1919 | |
| (816) 361-1930 |
| Full Name | Dr William M Beary |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 29 Years |
| Location | 6420 Prospect Ave Ste T303, Kansas City, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598722993 | NPI | - | NPPES |
| 200232312 | Medicaid | MO | |
| 200365450A | Medicaid | KS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 0429814 (Kansas) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | 2002025183 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Research Medical Center | Kansas city, MO | Hospital |
| Belton Regional Medical Center | Belton, MO | Hospital |
| Cass Regional Medical Center | Harrisonville, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kansas City Pulmonology Practice Llc | 0042210502 | 13 |
News Archive
Excelimmune, Inc. (www.excelimmune.com) announced today that the National Institutes of Health (NIH) has awarded the company a Small Business Innovation Research (SBIR) grant to support research aimed at developing new treatments for Clostridium difficile (C. difficile) infection, employing Excelimmune's expertise in developing novel antibody therapies for human disease.
In a visible sign of data sharing leadership, Vivli, the Center for Clinical Research Da,ta has committed to serving the open science community through the launch of a COVID-19 portal for sharing of completed interventional treatment trial data.
New York University chemists have developed a computational approach for determining the viability and suitability of complex molecular structures—an advancement that could aid in the development of pharmaceuticals as well as a range of other materials.
How does an industry that sells deadly, addictive products remain one of the leading consumer product industries in the world? The answer includes new products, savvy marketing and expensive public image campaigns. ClearWay Minnesota today released Unfiltered: A Revealing Look at Today's Tobacco Industry, a campaign that shines a light on how the tobacco industry has continued to evolve and thrive, despite billion dollar settlements designed to change the way the industry did business in the last decade.
› Verified 7 days ago
| Entity Name | Kansas City Pulmonology Practice Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134208150 PECOS PAC ID: 0042210502 Enrollment ID: O20070105000445 |
News Archive
Excelimmune, Inc. (www.excelimmune.com) announced today that the National Institutes of Health (NIH) has awarded the company a Small Business Innovation Research (SBIR) grant to support research aimed at developing new treatments for Clostridium difficile (C. difficile) infection, employing Excelimmune's expertise in developing novel antibody therapies for human disease.
In a visible sign of data sharing leadership, Vivli, the Center for Clinical Research Da,ta has committed to serving the open science community through the launch of a COVID-19 portal for sharing of completed interventional treatment trial data.
New York University chemists have developed a computational approach for determining the viability and suitability of complex molecular structures—an advancement that could aid in the development of pharmaceuticals as well as a range of other materials.
How does an industry that sells deadly, addictive products remain one of the leading consumer product industries in the world? The answer includes new products, savvy marketing and expensive public image campaigns. ClearWay Minnesota today released Unfiltered: A Revealing Look at Today's Tobacco Industry, a campaign that shines a light on how the tobacco industry has continued to evolve and thrive, despite billion dollar settlements designed to change the way the industry did business in the last decade.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr William M Beary, MD 6420 Prospect Ave, T303, Kansas City, MO 64132-4147 Ph: (816) 333-1919 | Dr William M Beary, MD 6420 Prospect Ave Ste T303, Kansas City, MO 64132-4146 Ph: (816) 333-1919 |
News Archive
Excelimmune, Inc. (www.excelimmune.com) announced today that the National Institutes of Health (NIH) has awarded the company a Small Business Innovation Research (SBIR) grant to support research aimed at developing new treatments for Clostridium difficile (C. difficile) infection, employing Excelimmune's expertise in developing novel antibody therapies for human disease.
In a visible sign of data sharing leadership, Vivli, the Center for Clinical Research Da,ta has committed to serving the open science community through the launch of a COVID-19 portal for sharing of completed interventional treatment trial data.
New York University chemists have developed a computational approach for determining the viability and suitability of complex molecular structures—an advancement that could aid in the development of pharmaceuticals as well as a range of other materials.
How does an industry that sells deadly, addictive products remain one of the leading consumer product industries in the world? The answer includes new products, savvy marketing and expensive public image campaigns. ClearWay Minnesota today released Unfiltered: A Revealing Look at Today's Tobacco Industry, a campaign that shines a light on how the tobacco industry has continued to evolve and thrive, despite billion dollar settlements designed to change the way the industry did business in the last decade.
› Verified 7 days ago
Maria Akram Sheikh, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4401 Wornall Rd, Kansas City, MO 64111 Phone: 816-932-0340 Fax: 816-932-3148 | |
Dr. Philip Barigbi Augustine, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4150 N Mulberry Dr, Kansas City, MO 64116 Phone: 816-912-4539 Fax: 855-813-6642 | |
Lucas Vocelka, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2340 E Meyer Blvd, Bldg 2, Suite 392, Kansas City, MO 64132 Phone: 816-444-7977 Fax: 630-528-9578 | |
Karla L Houston-gray, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1004 Carondelet Dr Ste 300, Kansas City, MO 64114 Phone: 816-942-4500 Fax: 816-941-4504 | |
Carl D Dirks, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4320 Wornall Rd, Suite 65, Kansas City, MO 64111 Phone: 816-932-6100 Fax: 816-932-9002 | |
Michelle L Dew, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4330 Wornall Rd, Suite 2000, Kansas City, MO 64111 Phone: 816-931-1883 Fax: 816-756-3645 | |
Brenda J Rogers, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2401 Gillham Rd, Kansas City, MO 64108 Phone: 816-234-3000 |